2024-12-12 – Press Releases – www.prnewswire.com
YANTAI, China, Dec. 13, 2024 /PRNewswire/ — On the morning of December 12, 2024 (UTC-6), at the Poster Spotlight Session “Novel HER2 Therapeutics” of the 47th San Antonio Breast Cancer Symposium (SABCS), RemeGen Co. Ltd. (“RemeGen”) (9995.HK, 688331.SH) presented for the first time the…
